Efficacy and Safety Study of Binodenoson in Assessing Cardiac Ischemia

PHASE3CompletedINTERVENTIONAL

Enrollment

419

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions

Coronary Artery Disease

Interventions

DRUG

binodenoson

30-second intravenous injection (bolus) of binodenoson (1.5 mcg/kg) and a 6-minute intravenous infusion of placebo

DRUG

adenosine

30-second intravenous injection (bolus) of placebo and a 6-minute intravenous infusion of adenosine (140 mcg/kg/minute)